Fentazin (perphenazine), a phenothiazine, increases circulating prolactin levels by inhibiting prolactin inhibiting factor. (Pearson et al., Trans. Am. Physicns, 1969, 32, 225) . Female Sprague-Dawley rats aged 30 days were started on daily subcutaneous injections either of Fentazin (5 mg/kg body weight) or vehicle (02% citric acid). Both groups of animals received DMBA (5 mg i.v.) when aged 50 days. The in vitro metabolism of [3H]dehydroepiandrosterone and [3H]testosterone was determined in adenocarcinomata subsequently appearing in the rats.
Adenocarcinomata from the Fentazin treated animals displayed greater metabolism of testosterone than those from control animals whereas the transformation of dehydroepiandrosterone was similar in both groups. The increase in testosterone metabolism was largely accounted for by a significant increase in 5-co-reductase activity. These results suggest that prolactin may modify the intracellular environment of steroid hormones in rat adenocarcinomata. Thirty-two patients with acute nonlymphocytic leukaemia (22 myeloid, 2 monoblastic, 3 myelomonoblastic, 2 promyelocytic, 3 blast crisis) have been treated with combined daunorubincin 1 mg/kg i.v. x 1 cytosine arabinoside 2 mg/kg x 5 and vincristine 1 mg i.v. x 1 in 5-day cycles and followed by 6-mercaptopurine and cyclophosphamide when remission was induced, with reinduction at 3-monthly intervals. Sixty per cent of patients went into full remission, which has lasted from 6 months to 2 years. Two patients with acute promyelocytic leukaemia developed coagulation problems which were controlled by EACA and then went into full remission. Two patients with acute monoblastic and myelomonoblastic leukaemia went into full remission on this programme.
One patient who was extremely ill during induction of remission developed a severe neuropathy. Alopecia was a problem with higher dosage of daunorubicin and cardiotoxicity occurred in 2 patients. Reinduction at 3-monthly intervals with triple chemotherapy was smooth and in our opinion contributes to the prolonged remission in these cases. Age group did not significantly affect remission rate. The combination of estimations of carcinoembryonic antigen (CEA) with certain serum enzymes (y glutamyl transpeptidase (yGT) and leucine aminopeptidase (LAP) can enhance the separation of controls from patients with primary colorectal cancer and those with metastatic involvement of the liver.
yGT contributes to this discrimination in both the primary and secondary case. The mean values were: (i) control 13-94 ± 7-65; (ii) primary 21'65 i 12-20 and (iii) metastatic 139-34 ± 96-22.
On the other hand, the LAP was elevated only in metastatic involvement of the liver and did not rise before the yGT exceeded 100 units: (i) control 41-55 ± 9-20; (ii) primary 40-27 + 14-38 and (iii) metastatic 96-81 + 50-39.
The combination of CEA and yGT was particularly advantageous for separating pelvic or local recurrence from hepatic metastases. In the former there was a moderate rise of CEA but little increase of yGT whereas in hepatic metastases the yGT was elevated. These tests, when considered with relevant clinical history, can readily distinguish hepatic metastases from non-malignant disease of the liver. Approximately 10% of outpatients who were symptom free and without apparent recurrence showed a moderate elevation (40-100 units) of yGT without corresponding increase in CEA, when examined 3 months to 13 years after excision of the primary. Bone scanning is recognized to be more effective than radiology in the demonstration of skeletal metastases. The established bone scanning agents, strontium-87m and fluorine-18, are not entirely satisfactory. Recently, technetium labelled phosphate compoundspolyphosphate, pyrophosphate and ethane hydroxy diphosphonate-have become available for skeletal scanning. We have now performed over 200 consecutive studies in man and no toxic effects have been noted. A study of the relative efficacy of these agents in patients with metastatic disease, and in normal subjects, is described. Adequate visualization of the skeleton has been obtained and comparison of the scans and x-rays suggests that these compounds are of definite value in the investigation of malignant disease of the skeleton. Cultured Yoshida lymphosarcoma cells resistant (R) to treatment with sulphur mustard suffered much less chromosome damage than sensitive (S) cells in spite of equal alkylation of DNA, RNA and protein in R and S cells. The R and S cell lines were equally sensitive to x-rays and sustained the same amount of chromosome damage. DNA repair synthesis was equal in R and S cells after sulphur mustard or x-ray treatment.
Much less chromosome damage was found in L5178Y mouse lymphoma cells resistant to x-irradiation than in radiationsensitive cells but the amount of DNA repair was similar.
Thus, drug and radiation resistance is accompanied by, and perhaps mediated through, a reduced amount of induced chromosome damage but is not quantitatively related to DNA repair capacity. The effects of IRCF 159 on macromolecular synthesis in cultured cells led to the suggestion of a possible radiomimetic action (Creighton and Birnie, Int. J. Cancer, 1970, 5, 47) . We have found a dose-dependent inhibition of the growth (cell numbers) of BHK-21S cells approaching 100% at >100 ,umol/l (27 ug/ml). Continuous exposure to a range of doses >5 ,tmol/l produced a hyperbolic decrease in survival (colony forming assay). Such a response is generally associated with antimetabolites but in this case the hyperbolic curve seems more likely to be caused by a protective effect which is seen with ICRF 159 at high doses (ca. 400 tzmol/l).
MECHANISM OF ACTION STUDIES
Time lapse cinemicrography has shown that the increase in cell numbers is inhibited due to an interference with cytokinesis. However, the cells continue to grow and accumulate DNA, RNA and protein and many become multinucleate. Comparative studies indicate that this cell line is particularly sensitive in this respect. Cells with a similar multinucleate morphology were obtained following treatment with x-radiation
